Suppr超能文献

米安色林对糖尿病性神经病理性疼痛的抗痛觉过敏和抗异常性疼痛作用:作用机制研究。

Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: a study on mechanism of action.

机构信息

Anadolu University, Faculty of Pharmacy, Department of Pharmacology, 26470 Eskişehir, Turkey.

Anadolu University, Faculty of Pharmacy, Department of Pharmacology, 26470 Eskişehir, Turkey.

出版信息

Eur J Pharmacol. 2015 Jun 5;756:92-106. doi: 10.1016/j.ejphar.2015.02.048. Epub 2015 Mar 11.

Abstract

This study used various experimental pain methods to investigate the effects of subacute mianserin administration on diabetes-induced neuropathic pain in rats. The effect of mianserin on hyperalgesia occurring in connection with peripheral diabetic neuropathy was examined using the Randall-Selitto (mechanical nociceptive stimulus), Hargreaves (thermal nociceptive stimulus), and cold-plate (4°C, thermal nociceptive stimulus) tests. The dynamic plantar aesthesiometer, which measures the threshold values for mechanical stimuli, was used for allodynia studies. Thermal allodynia was evaluated with the warm-plate (38°C) test. At 30 and 45 mg/kg, mianserin effectively improved mechanical and thermal hyperalgesia occurring in connection with diabetic neuropathy. Subacute administration of mianserin also reduced diabetes-associated mechanical and thermal allodynia. The ability of mianserin to reduce diabetic neuropathic pain was comparable to that of pregabalin (10mg/kg). The antihyperalgesic and antiallodynic effects of mianserin were reversed with α-methyl-para-tyrosine methyl ester (AMPT, an inhibitor of catecholamine synthesis), phentolamine (a non-selective α-adrenoceptor antagonist), propranolol (a non-selective β-adrenoceptor antagonist), and naloxone (a non-selective opioid receptor antagonist) administrations. The same effects were not reversed, however, by para-chlorophenylalanine methyl ester (PCPA; an inhibitor of serotonin synthesis). These results suggest that the beneficial effect of mianserin on diabetic neuropathic pain is mediated through an increase in catecholamine levels in the synaptic cleft as well as through interactions with both subtypes of adrenoceptors and opioid receptors. Considering that mianserin exhibits simultaneous antidepressant and antinociceptive effects, this drug could provide a good alternative for treating the pain associated with diabetic neuropathy and the mood disorders caused directly by diabetes.

摘要

本研究采用多种实验性疼痛方法,探讨米氮平在大鼠亚急性糖尿病神经病理性疼痛中的作用。通过 Randall-Selitto(机械性疼痛刺激)、Hargreaves(热痛刺激)和冷板(4°C,热痛刺激)试验,观察米氮平对周围性糖尿病性神经病引起的痛觉过敏的影响。动态足底测痛仪用于所有痛觉过敏研究,用于测量机械刺激的阈值。使用热板(38°C)试验评估热痛觉过敏。米氮平 30 和 45mg/kg 有效改善了与糖尿病神经病变相关的机械性和热痛觉过敏。亚急性米氮平给药还降低了糖尿病相关的机械性和热痛觉过敏。米氮平降低糖尿病性神经病理性疼痛的能力与普瑞巴林(10mg/kg)相当。米氮平的抗痛觉过敏和抗痛觉过敏作用可被α-甲基-para-酪氨酸甲酯(AMPT,儿茶酚胺合成抑制剂)、苯芐胺(非选择性α-肾上腺素能受体拮抗剂)、心得安(非选择性β-肾上腺素能受体拮抗剂)和纳洛酮(非选择性阿片受体拮抗剂)逆转,但不能被对氯苯丙氨酸甲酯(PCPA;5-羟色胺合成抑制剂)逆转。这些结果表明,米氮平对糖尿病性神经病理性疼痛的有益作用是通过增加突触间隙儿茶酚胺水平以及与两种亚型肾上腺素能受体和阿片受体相互作用来介导的。鉴于米氮平同时具有抗抑郁和镇痛作用,该药可能为治疗糖尿病性神经病变相关疼痛和糖尿病直接引起的情绪障碍提供一种良好的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验